Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'

被引:1
作者
Satis, Hasan [1 ]
Aydemir, Ergin [2 ]
Izmirlioglu, Kerem [2 ]
Tufan, Abdurrahman [1 ]
机构
[1] Gazi Univ, Dept Internal Med, Div Rheumatol, Ankara, Turkey
[2] Gazi Univ, Dept Internal Med, Ankara, Turkey
关键词
amyloidosis; familial Mediterranean fever; interleukin 1 receptor antagonist protein; inflammation;
D O I
10.1136/annrheumdis-2020-218901
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:1
相关论文
共 3 条
[1]  
Babaoglu H, 2020, CLIN EXP RHEUMATOL, V38, pS42
[2]   Predictors of persistent inflammation in familial Mediterranean fever and association with damage [J].
Babaoglu, Hakan ;
Armagan, Berkan ;
Bodakci, Erdal ;
Satis, Hasan ;
Atas, Nuh ;
Sari, Alper ;
Bilge, Nazife Sule Yasar ;
Salman, Reyhan Bilici ;
Yardimci, Gozde Kubra ;
Guler, Aslihan Avanoglu ;
Karadeniz, Hazan ;
Kilic, Levent ;
Ozturk, Mehmet Akif ;
Goker, Berna ;
Haznedaroglu, Seminur ;
Kalyoncu, Umut ;
Kasifoglu, Timucin ;
Tufan, Abdurrahman .
RHEUMATOLOGY, 2021, 60 (01) :333-339
[3]   Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial [J].
Ozen, Seza ;
Ben-Cherit, Eldad ;
Foeldvari, Ivan ;
Amarilyo, Gil ;
Ozdogan, Huri ;
Vanderschueren, Steven ;
Marzan, Katherine ;
Kahlenberg, J. Michelle ;
Dekker, Elise ;
De Benedetti, Fabrizio ;
Kone-Paut, Isabelle .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10) :1362-1369